A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.

Clinical trial NCT07658534 · RECRUITING

Trial details

NCT number: NCT07658534
Sponsor: Shanghai Ark Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2026-03-03
Primary completion: 2028-12-01
Enrollment: 290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.